INSTITUTO DE INVESTIGACIONES METABOLICAS (IDIM); Oncology

Ciudad Autonoma Buenos Aires C1012AAR

0 studies enrolling now · 1 studies all time

What they study most

Triple Negative Breast Cancer

Studies at this site

• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early